Delivery Order SPE2DB20D3111-SPE2DB23FA7UT
Award Date 4/18/23
Potential Completion Date 4/19/23
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The delivery order has a ceiling value of $1,773.66 and a performance period ending on March 7, 2023. The contract is a Firm Fixed Price arrangement and does not...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The Delivery Order has a ceiling value of $1,534.83 and a period of performance through October 11, 2023. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $17,453.56. It was awarded on April 7, 2025, with an Ultimate Completion Date of April 8, 2025. The contract is not designated as a Set-Aside. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $6,153.96 and a completion date of April 16, 2025. This award is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,270.45, is for the supply of 4,568,118,790 tablets of 4 mg Ondansetron HCL, a medication used to prevent nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,753.70 and a completion date of February 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen also holds a larger Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,616.70, is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $18,138.87 and runs through February 28, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite...